
IFF Stock Forecast & Price Target
IFF Analyst Ratings
Bulls say
International Flavors & Fragrances (IFF) has demonstrated a significant improvement in financial performance, with the Return on Capital (ROC) rising from 2.77% to 5.32% over the last twelve months, and forecasts suggesting further growth to 6.37% in the near term. Taste sales exhibited a year-over-year increase of 3%, amounting to $631 million, with a stronger 6% growth on a currency-neutral basis, attributed to broad-based gains across various regions. As the largest specialty ingredients producer globally, IFF’s diverse portfolio, including strength in the health and biosciences sector, positions the company favorably for sustained profitability and growth.
Bears say
International Flavors & Fragrances is projected to experience a decline in net sales revenue, estimated at 5.56% to $10.68 billion over the next twelve months due to the divestiture of significant business units, including Pharma Solutions. Additionally, the company's performance for the 12 months ending June 2025 indicates that net sales revenue remained mostly flat year-over-year at $11.30 billion, highlighting stagnation in revenue growth. These factors, combined with potential challenges in meeting investment objectives, contribute to a negative outlook for the company's stock performance.
This aggregate rating is based on analysts' research of International Flavors & Fragrances and is not a guaranteed prediction by Public.com or investment advice.
IFF Analyst Forecast & Price Prediction
Start investing in IFF
Order type
Buy in
Order amount
Est. shares
0 shares